Member of Lyonbiopole
AUROBAC THERAPEUTICS is a biopharmaceutical company created in 2022 by 3 renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to become a global leader in the fight against bacterial infections, Antimicrobial Resistance (AMR) and their consequences in acute hospital settings.
We focus our efforts to develop the next generation of antimicrobial and acute care products, following a targeted precision medicine approach, i.e. associated with rapid diagnostics to support product use.
Application market: Infectious Diseases
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Others
Created on nov. 10th, 2021 - 23 employees
Address
29 Avenue Tony Garnier 69007 Lyon
You must be logged in and a member of Lyonbiopôle to see the contacts.
